Outset Medical (OM) CEO Trigg sells 1,795 shares in tax cover trade

Rhea-AI Filing Summary

Outset Medical, Inc. Chair and CEO Leslie Trigg reported a sale of 1,795 shares of Common Stock on January 7, 2026 at $4.27 per share. According to the footnote, this was a required "sell to cover" transaction to satisfy tax withholding on 4,904 shares underlying performance stock units that were earned based on performance criteria and vested and released on January 6, 2025, so it was not a discretionary trade.

After this transaction, Trigg beneficially owned 119,617 shares directly, plus 41,666 shares held indirectly through the Trigg 2002 Rev Trust and 584 shares held indirectly through the Trigg Family Trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Trigg Leslie

(Last) (First) (Middle)

3052 ORCHARD DRIVE

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/07/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/07/2026		S(1)		1,795	D	$4.27	119,617	D
Common Stock								41,666	I	Trigg 2002 Rev Trust
Common Stock								584	I	Trigg Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 4,904 shares of Common Stock underlying PSUs (i) which were, as previously reported, originally earned based on the achievement of applicable performance criteria as of December 31, 2024 or January 6, 2025, as applicable, as certified by the Compensation Committee of the Issuer's Board of Directors on January 17, 2025 and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

	By: John L Brottem For: Leslie Trigg	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did OM Chair and CEO Leslie Trigg report?

Leslie Trigg reported selling 1,795 shares of Outset Medical Common Stock on January 7, 2026 at a price of $4.27 per share.

Why did Leslie Trigg sell 1,795 OM shares?

The 1,795 shares were sold to cover tax withholding obligations related to 4,904 shares of Common Stock underlying performance stock units that had vested, in a "sell to cover" transaction that the filing states was not a discretionary trade.

How many OM shares does Leslie Trigg own after this Form 4 transaction?

Following the reported sale, Leslie Trigg beneficially owned 119,617 shares directly, 41,666 shares indirectly through the Trigg 2002 Rev Trust, and 584 shares indirectly through the Trigg Family Trust.

What is Leslie Trigg’s role at Outset Medical (OM)?

Leslie Trigg is reported as both a Director and an Officer of Outset Medical, Inc., with the officer title of Chair and CEO.

Were any derivative securities reported in this OM Form 4 filing?

Table II for derivative securities is included in the form structure, but there are no derivative security transactions listed with amounts or dates in the provided content.

What equity awards were connected to the tax-related OM share sale?

The tax-related sale was connected to 4,904 shares of Common Stock underlying performance stock units that were earned based on performance criteria as of December 31, 2024 or January 6, 2025, certified on January 17, 2025, and vested and released on January 6, 2025.